14-day Premium Trial Subscription Try For FreeTry Free
$137.20
-3.90 (-2.76%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 3rd May 2024 ASND stock ended at $137.20. This is 2.76% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.33% from a day low at $135.16 to a day high of $142.36.
90 days $133.39 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Jul 19, 2022 $87.18 $88.02 $85.50 $87.94 156 481
Jul 18, 2022 $85.86 $88.57 $85.17 $85.50 681 459
Jul 15, 2022 $86.34 $86.34 $82.70 $85.33 862 284
Jul 14, 2022 $87.48 $88.32 $85.21 $85.57 162 803
Jul 13, 2022 $89.33 $92.42 $87.76 $88.57 321 887
Jul 12, 2022 $91.28 $92.65 $87.71 $90.06 283 561
Jul 11, 2022 $93.22 $93.22 $90.52 $90.77 241 159
Jul 08, 2022 $92.64 $94.57 $90.60 $93.61 193 126
Jul 07, 2022 $89.48 $95.43 $89.48 $94.00 310 345
Jul 06, 2022 $95.49 $95.80 $88.76 $89.50 347 563
Jul 05, 2022 $91.46 $95.72 $91.15 $95.39 142 884
Jul 01, 2022 $92.96 $93.89 $91.83 $92.60 145 925
Jun 30, 2022 $93.10 $95.33 $91.62 $92.96 312 404
Jun 29, 2022 $93.46 $95.48 $90.44 $94.20 254 507
Jun 28, 2022 $94.47 $94.95 $91.37 $93.15 486 433
Jun 27, 2022 $91.48 $95.78 $90.82 $95.10 476 535
Jun 24, 2022 $92.67 $93.89 $86.23 $91.09 785 925
Jun 23, 2022 $86.55 $92.57 $84.84 $91.47 299 112
Jun 22, 2022 $83.92 $88.42 $83.08 $85.73 369 535
Jun 21, 2022 $85.25 $87.94 $84.35 $85.50 339 497
Jun 17, 2022 $79.21 $85.19 $79.21 $83.92 344 131
Jun 16, 2022 $81.36 $83.68 $77.64 $78.60 393 490
Jun 15, 2022 $82.21 $84.45 $81.25 $83.19 360 176
Jun 14, 2022 $80.51 $81.33 $78.21 $81.24 219 936
Jun 13, 2022 $79.12 $82.07 $77.28 $79.96 387 858
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT